Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vascular filling, also known as fluid expansion or volume expansion, is a therapeutic intervention involving the intravenous administration of fluids to increase intravascular volume and improve cardiac preload. In the context of right ventricular (RV) infarction, it has traditionally been the first-line treatment to maintain RV output by optimizing filling pressures. However, this specific trial by Assistance Publique - Hôpitaux de Paris (AP-HP) investigates whether this approach might be deleterious due to RV dilation and ventricular interdependence, comparing it against the diuretic furosemide. In this study, vascular filling is standardized as the infusion of 500 mL of 0.9% Sodium Chloride (normal saline) over 30 minutes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on vascular filling.